D
Dalton James Surmeier
Researcher at Northwestern University
Publications - 43
Citations - 3161
Dalton James Surmeier is an academic researcher from Northwestern University. The author has contributed to research in topics: Medium spiny neuron & Parkinson's disease. The author has an hindex of 20, co-authored 43 publications receiving 2652 citations.
Papers
More filters
Journal ArticleDOI
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
Jose A. Obeso,Maria Stamelou,Maria Stamelou,Christopher G. Goetz,W. Poewe,Anthony E. Lang,Anthony E. Lang,Daniel Weintraub,David J. Burn,Glenda M. Halliday,Glenda M. Halliday,Erwan Bezard,Erwan Bezard,Serge Przedborski,Stéphane Lehéricy,David J. Brooks,David J. Brooks,John C. Rothwell,Mark Hallett,Mahlon R. DeLong,Connie Marras,Caroline M. Tanner,Caroline M. Tanner,G. W. Ross,J. W. Langston,Christine Klein,V. Bonifati,Joseph Jankovic,Andres M. Lozano,Günther Deuschl,Hagai Bergman,Eduard Tolosa,Mayela Rodríguez-Violante,Stanley Fahn,Ronald B. Postuma,Daniela Berg,Kenneth Marek,David G. Standaert,Dalton James Surmeier,C. W. Olanow,Jeffrey H. Kordower,Paolo Calabresi,Anthony H.V. Schapira,A. J. Stoessl,A. J. Stoessl +44 more
TL;DR: This multiple‐author article provides a historical state‐of‐the‐art account of what has been achieved, the current situation, and how to progress toward resolving Parkinson's disease.
Journal ArticleDOI
Recurrent Collateral Connections of Striatal Medium Spiny Neurons Are Disrupted in Models of Parkinson's Disease
TL;DR: Recurrent collateral connections between MSNs are not random but rather differentially couple D1 and D2 MSNs, potentially contributing to pathological alterations in MSN activity patterns and psychomotor symptoms in Parkinson's disease models.
Journal ArticleDOI
Corticostriatal and Thalamostriatal Synapses Have Distinctive Properties
TL;DR: Differences in release probability and short-term synaptic plasticity suggest that corticostriatal and thalamostRIatal projection systems code information in temporally distinct ways, constraining how they regulate striatal circuitry.
Journal ArticleDOI
The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
TL;DR: Analysis revealed that isradipine produced a dose-dependent sparing of DA fibers and cell bodies at concentrations achievable in humans, suggesting that is Radipine is a potentially viable neuroprotective agent for PD.
Journal ArticleDOI
The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
TL;DR: The hypothesis that the primary factor driving neurodegenerative changes in PD is the metabolic stress created by Ca²⁺ entry is examined, particularly in the face of genetic or environmental factors that compromise oxidative defenses or proteostatic competence.